Characterization of Adult Subjects for Asthmatic Research Studies (CASA)

This study is currently recruiting participants.
Verified January 2013 by University of California, San Francisco
Sponsor:
Information provided by (Responsible Party):
John V. Fahy, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01508078
First received: January 6, 2012
Last updated: January 25, 2013
Last verified: January 2013
  Purpose

This study is designed to characterize subjects in terms of the nature and severity of their asthma and in terms of conditions that may alter the clinical expression of asthma. Some features will be obtained in all subjects. These include a medical history and baseline lung function tests. This characterization forms the basis for our database that facilitates research protocols.


Condition
Asthma

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: Characterization of Adult Subjects for Asthmatic Research Studies

Resource links provided by NLM:


Further study details as provided by University of California, San Francisco:

Estimated Enrollment: 2000
Groups/Cohorts
Asthmatics
Otherwise healthy asthmatic subjects
Healthy controls

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Asthmatics and healthy control

Criteria

Inclusion Criteria:

  • Age 18 years and older

Exclusion Criteria:

  • History of lung disease other than asthma
  • An upper respiratory tract infection or an exacerbation of their asthma within the preceding 4-6 weeks.
  • Persons who have smoked > 5 cigarettes per month and have a total pack-year smoking history > 10 packs.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01508078

Locations
United States, California
University of California, San Francisco Recruiting
San Francisco, California, United States, 94143
Contact: John Fahy, MD     415-502-4849        
Sponsors and Collaborators
University of California, San Francisco
Investigators
Principal Investigator: John Fahy, MD University of California, San Francisco
  More Information

No publications provided

Responsible Party: John V. Fahy, Professor in Residence, University of California, San Francisco
ClinicalTrials.gov Identifier: NCT01508078     History of Changes
Other Study ID Numbers: 10-01627
Study First Received: January 6, 2012
Last Updated: January 25, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on May 16, 2013